These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18988770)

  • 1. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
    Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
    Becker CM; Sampson DA; Short SM; Javaherian K; Folkman J; D'Amato RJ
    Fertil Steril; 2006 Jan; 85(1):71-7. PubMed ID: 16412733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
    Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
    Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
    Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS; Giachelli CM; Scatena M
    Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin derived antiangiogenic peptide LRR5 inhibits endothelial cell migration by interfering with VEGF-stimulated NO release.
    Fan H; Sulochana KN; Chong YS; Ge R
    Int J Biochem Cell Biol; 2008; 40(10):2120-8. PubMed ID: 18373940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
    Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
    J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on "Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis".
    Di Serio C; Pellerito S; Tarantini F
    J Pharmacol Exp Ther; 2008 Jan; 324(1):404-5; author reply 406-7. PubMed ID: 18094323
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
    Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
    Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis.
    Tong Y; Zhang X; Zhao W; Zhang Y; Lang J; Shi Y; Tan W; Li M; Zhang Y; Tong L; Lu H; Lin L; Ding J
    Eur J Pharmacol; 2004 Jun; 494(2-3):101-9. PubMed ID: 15212963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
    Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
    Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis.
    Ahluwalia A; Li A; Cheng G; Deng X; Tarnawski AS
    J Physiol Pharmacol; 2009 Jun; 60(2):29-34. PubMed ID: 19617642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
    You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
    Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
    Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.